VoravitRatanatharathornMD

Oncology • Detroit, MI

Hematologic Oncology

Professor, Internal Medicine, Wayne State University School of Medicine

Join to view full profile

Dr. Ratanatharathorn is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ratanatharathorn's full profile

Already have an account?

Office
4100 John R St
Hwcrc 4th Fl
Detroit, MI 48201
Phone(800) 527-6266
Fax(313) 576-8767
Is this information wrong?

Education & Training

Thomas Jefferson UniversityResidency, Internal Medicine, 1973 - 1975
Harper - Grace HospitalsInternship, Internal Medicine, 1972 - 1973
Mahidol University Faculty of MedicineClass of 1971

Certifications & Licensure

PA State Medical License 1974 - 1976
MI State Medical License 1973 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study of Nivolumab in Subjects With Hodgkin's Lymphoma (Registrational) (CheckMate 205) Start of enrollment: 2014 Jul 01Younes, A.,Timmerman, J.,Cohen, J.,Fanale, M.,Armand, P.,s, R.i.,0003, S.,0004, S.,0005, S.,0012, S.,0014, S.,0015, S.,0016, S.,0017, S.,0019, S.,0020, S.,0022, S.,0023, S.,0025, S.,0026, S.,0027, S.,0028...
Allo vs. Hypomethylating/Best Supportive Care in MDS (Blood and Marrow Transplant Clinical Trials Network #1102) Start of enrollment: 2013 Dec 01Gerds, A.,Artz, A.,Oran, B.,Cutler, C.,McCarty, J.,Wingard, J.,Benjamin, J.,McGuirk, J.,Johnson, L.,Horowitz, M.,Westervelt, P.,Kamble, R.,Maziarz, R.,Nakamura, R.,Shea, T.,Ratanatharathorn, V.,Chen, Y.
A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) Versus HLA-Haploidentical Related Bone Marrow (Haplo-BM) for Patients With Hematologic Malignancies (BM Start of enrollment: 2012 Jun 01Schiller, G.J.,Gul, Z.,Malone, A.K.,Salit, R.B.,Fauble, V.,Gregory, T.,O'Donnell, P.V.,Mineishi, S.,Horowitz, M.M.,McCarthy, P.L.,William, B.,Brunstein, C.G.,Little, J.A.,Ratanatharathorn, V.,Cooper, B.W....
Phase I/II Study of Dasatinib in Recipients of Allogeneic Stem Cell Transplantation for Hematologic Malignancies. Start of enrollment: 2012 May 01Uberti, J.P.,Schiffer, C.A.,Ratanatharathorn, V.,Lum, L.G.,Ayash, L.J.
Phase I/II Study of Dasatinib in Recipients of Autologous Stem Cell Transplantation for Hematologic Malignancies. Start of enrollment: 2012 May 01Ayash, L.J.,Uberti, J.P.,Schiffer, C.A.,Ratanatharathorn, V.,Lum, L.G.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications Start of enrollment: 2011 Oct 01Abdel-Mageed, A.,Adams, R.,Agura, E.,Akard, L.,Al-Homsi, A.S.,Anderson, E.,Andreansky, M.,Andrey, J.W.,Aquino, V.,Avigan, D.,Bachier, C.,Ball, E.,Ballen, K.,Barker, J.,Bayer, R.L.,Berryman, R.B.,Bhatia, M...
A Pilot Study of Double Cord Blood Stem Cell Transplantation in Patients With Hematologic Malignancies Start of enrollment: 2007 Jan 01Ratanatharathorn, V.
Investigation of the Total Nucleated Cell Yield of Cord Blood Units Collected From African-American Donors in Correlation With Gestational and Other Health Variables Start of enrollment: 2005 Aug 01Ratanatharathorn, V.
Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants Start of enrollment: 2003 Nov 01Gamis, A.,Segal, B.,Lee, C.,Anasetti, C.,Salzman, D.,Ball, E.,Stadtmauer, E.,Nicholson, H.S.,Lazarus, H.,Brown, J.,Andrey, J.,Burik, J.v.,Kurtzberg, J.,Brochstein, J.,DiPersio, J.,Wingard, J.,McGuirk, J.,...
Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT Juan Varela, MD, PhD
Join now to see all

Publications & Presentations

PubMed

Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation.
Dipenkumar Modi, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti> ;Bone Marrow Transplantation. 2020 Oct 16
G-CSF use post peripheral blood stem cell transplant is associated with faster neutrophil engraftment, shorter hospital stay and increased incidence of chronic GVHD
Vijendra Singh, Hyejeong Jang, Seongho Kim, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol> ;Leukemia & Lymphoma. 2020 Oct 12
Absolute lymphocyte count on the first day of thymoglobulin predicts relapse-free survival in matched unrelated peripheral blood stem cell transplantation.
Dipenkumar Modi, Seongho Kim, Malini Surapaneni, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol> ;Leukemia & Lymphoma. 2020 Aug 11
Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?
Nadine Abdallah, Seongho Kim, Lois Ayash, Scott Klimecki, Marie Ventimiglia, Asif Alavi, Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol> ;Bone Marrow Transplantation. 2020 Aug 1
Lenalidomide maintenance after second autologous stem cell transplant improves overall survival in multiple myeloma
Dipenkumar Modi, Jie Chi, Seongho Kim, Lois Ayash, Asif Alavi, Andrew Kin, Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol> ;Leukemia & Lymphoma. 2020 Apr 9
R-BEAM versus Reduced-Intensity Conditioning Regimens in Patients Undergoing Allogeneic Stem Cell Transplantation for Relapsed Refractory Diffuse Large B Cell Lymphoma.
Dipenkumar Modi, Seongho Kim, Malini Surapaneni, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn, Abhinav Deol, Joseph P. Uberti> ;Biology of Blood and Marrow Transplantation. 2020 Apr 1
Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts.
Harsh Shah, Seongho Kim, Paramveer Singh, Asif Alavi, Voravit Ratanatharathorn, Lois Ayash, Joseph P. Uberti, Abhinav Deol> ;American Journal of Hematology. 2020 Feb 1
Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.
Dipenkumar Modi, Jing Christine Ye, Malini Surapaneni, Vijendra Singh, Wei Chen, Hyejeong Jang, Abhinav Deol, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn, Joseph ...> ;American Journal of Hematology. 2019 Jul 10
Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma.
Modi, D., Surapaneni, M., Kim, S., Ayash, L., Alavi, A., Ratanatharathorn, V., Deol, A., Uberti, J. P.> ;Leukemia research. 2019 Jun 23
Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome.
Dipenkumar Modi, Seongho Kim, Vijendra Singh, Lois Ayash, Asif Alavi, Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol> ;Leukemia & Lymphoma. 2019 Apr 23
Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
Divaya Bhutani, Charles Jaiyeoba, Seongho Kim, Paul H. Naylor, Joseph P. Uberti, Voravit Ratanatharathorn, Lois Ayash, Abhinav Deol, Asif Alavi, Sanjay G. Revankar, Pr...> ;Bone Marrow Transplantation. 2019 Jan 1
Immune T cells can transfer and boost anti-breast cancer immunity.
Archana Thakur, Ritesh Rathore, Sri Vidya Kondadasula, Joseph P. Uberti, Voravit Ratanatharathorn, Lawrence G. Lum> ;OncoImmunology. 2018 Aug 27
A phase II study of tacrolimus and thymoglobulin as graft‐versus‐host‐disease prophylaxis in related donor allogeneic hematopoietic cell transplantation
Dipenkumar Modi, Zaid Al-Kadhimi, Wei Chen, Hyejeong Jang, Abhinav Deol, Lois Ayash, Divaya Bhutani, Asif Alavi, Voravit Ratanatharathorn, Joseph P. Uberti> ;American Journal of Hematology. 2018 Aug 1
Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic synd...
Dipenkumar Modi, Abhinav Deol, Seongho Kim, Lois Ayash, Asif Alavi, Marie Ventimiglia, Divaya Bhutani, Voravit Ratanatharathorn, Joseph P. Uberti> ;Bone Marrow Transplantation. 2017 Sep 4
Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.
Dipenkumar Modi, Hyejeong Jang, Seongho Kim, Malini Surapaneni, Kamya Sankar, Abhinav Deol, Lois Ayash, Divaya Bhutani, Lawrence G. Lum, Voravit Ratanatharathorn, Rich...> ;Supportive Care in Cancer. 2017 Apr 2
3 citations
Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation.
Dipenkumar Modi, Hyejeong Jang, Seongho Kim, Abhinav Deol, Lois Ayash, Divaya Bhutani, Lawrence G. Lum, Voravit Ratanatharathorn, Richard Manasa, Kendra Mellert, Josep...> ;American Journal of Hematology. 2016 Sep 1
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm p...
Anas Younes, Armando Santoro, Margaret A. Shipp, Pier Luigi Zinzani, John M. Timmerman, Stephen M. Ansell, Philippe Armand, Michelle A. Fanale, Voravit Ratanatharathor...> ;Lancet Oncology. 2016 Sep 1
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies
Marcelo C. Pasquini, Jennifer Le-Rademacher, Xiaochun Zhu, Andrew S. Artz, John F. DiPersio, Hugo F. Fernandez, Shin Mineishi, Masaru Kamishohara, Jayesh Mehta, Yuki N...> ;Biology of Blood and Marrow Transplantation. 2016 Aug 1
3 citations
Targeting CD138−/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity
Lawrence G. Lum, Archana Thakur, Sri Vidya Kondadasula, Zaid Al-Kadhimi, Abhinav Deol, Elyse N. Tomaszewski, Hiroshi Yano, Dana Schalk, Lois Ayash, Jeffrey A. Zonder, ...> ;Biology of Blood and Marrow Transplantation. 2016 May 1
1 citations
BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Muthu Veeraputhiran, Tania Jain, Abhinav Deol, Lois Ayash, Seongho Kim, Gregory Dyson, Divaya Bhutani, Lawrence G. Lum, Voravit Ratanatharathorn, Joseph P. Uberti, Mun...> ;Clinical Lymphoma, Myeloma & Leukemia. 2015 Sep 1
Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.
Karen K. Ballen, Brent R. Logan, Mary J. Laughlin, Wensheng He, Daniel R. Ambruso, Sue Armitage, Rachel L. Beddard, Deepika Bhatla, William Hwang, Joseph E. Kiss, Gesi...> ;Biology of Blood and Marrow Transplantation. 2015 Apr 1
2 citations
Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohort.
Zartash Gul, E. M. Van Meter, Maheen Z. Abidi, Ivo Ditah, M. Abdul-Hussein, Abhinav Deol, Lois Ayash, Lawrence G. Lum, E.K. Waller, Voravit Ratanatharathorn, Joseph P....> ;Bone Marrow Transplantation. 2015 Mar 1
Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy
Mary Eapen, Brent R. Logan, FR Appelbaum, Joseph H. Antin, Claudio Anasetti, Daniel R. Couriel, Junfang Chen, Richard T. Maziarz, Philip L. McCarthy, Ryotaro Nakamura,...> ;Biology of Blood and Marrow Transplantation. 2015 Jan 1
10 citations
Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-versus-Host Disease
Divaya Bhutani, Gregory Dyson, Richard Manasa, Abhinav Deol, Voravit Ratanatharathorn, Lois Ayash, Muneer H. Abidi, Lawrence G. Lum, Zaid Al-Kadhimi, Joseph P. Uberti> ;Biology of Blood and Marrow Transplantation. 2015 Jan 1
Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT
Voravit Ratanatharathorn, Abhinav Deol, Lois Ayash, Simon Cronin, Divaya Bhutani, Lawrence G. Lum, Maheen Z. Abidi, Marie Ventimiglia, Kendra Mellert, Joseph P. Uberti> ;Bone Marrow Transplantation. 2015 Jan 1
Join now to see all

Abstracts/Posters

Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival
Voravit Ratanatharathorn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Re...
Voravit Ratanatharathorn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hemato...
Voravit Ratanatharathorn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member

Hospital Affiliations

DMC - Detroit Receiving HospitalDetroit, Michigan
DMC Harper University HospitalDetroit, Michigan
Karmanos Cancer CenterDetroit, Michigan